Study [mnob]
homocysteine [aapp, bacs]
Status [qlco]
Children [aggp]
Renal Failure, Chronic [dsyn]
Aims [idcn]
Vascular Diseases [dsyn]
Morbidity [qnco]
Mortality [qnco]
Renal Disease, End-Stage [dsyn]
Patients [podg]
Traditional [ftcn]
risk factors [qnco]
Atherosclerosis [dsyn]
Hyperhomocysteinemia [dsyn]
Additional [ftcn]
Accelerated atherosclerosis [fndg]
Thrombosis [patf]
Patients [podg]
Suggest [idcn]
Possibly [qlco]
homocysteine [aapp, bacs]
Induced [ftcn]
Endothelial cell [cell]
Injury [inpo]
Study [mnob]
Evaluation [ftcn]
homocysteine [aapp, bacs]
Status [qlco]
Children [aggp]
Renal Failure, Chronic [dsyn]
Suffering [mobd]
ESRD [dsyn]
Folic Acid [orch, phsu, vita]
Vitamin B 12 [orch, phsu, vita]
therapy [ftcn]
CORRECTION [inpr]
Hyperhomocysteinemia [dsyn]
Present [qnco]
Methods [inpr]
Study [mnob]
included [ftcn]
Patients [podg]
Renal Failure, Chronic [dsyn]
Regular [qlco]
Haemodialysis [topp]
treatment [ftcn]
Group I [inpr]
Medical [ftcn]
treatment [ftcn]
Group [idcn]
Ii [aapp]
Health [idcn]
Age [orga]
Sex [orgf]
matched [resa]
Group [idcn]
III [inpr]
Basal [spco]
homocysteine [aapp, bacs]
Folic Acid [orch, phsu, vita]
Vitamin B 12 [orch, phsu, vita]
Plasma [bdsu]
Activated [acty]
Protein [aapp, bacs]
Copyright [inpr]
Resistance [menp]
Measured [qlco]
Patients [podg]
homocysteine [aapp, bacs]
On [ftcn]
Regular [qlco]
Haemodialysis [topp]
On [ftcn]
treatment [ftcn]
Mu [inpr]
mol/L [qnco]
P NOS [aapp, imft]
Variation [qlco]
Group [idcn]
Values [qlco]
Activated Protein C Resistance [dsyn]
Folic Acid [orch, phsu, vita]
Vitamin B 12 [orch, phsu, vita]
Failed [ftcn]
Group [idcn]
Basal [spco]
homocysteine level [lbpr]
Patients [podg]
Previous [tmco]
History [ocdi]
Vaso-Occlusive Disease [dsyn]
Half [qnco]
Patients [podg]
Regular [qlco]
Haemodialysis [topp]
Group [idcn]
Ia [mamm]
N NOS [aapp, imft]
GIVEN [cnce]
Folic Acid [orch, phsu, vita]
mg% [qnco]
5-Formyl Tetrahydrofolate [orch, phsu, vita]
Active [ftcn]
Form [qlco]
Folic Acid [orch, phsu, vita]
Once weekly [tmco]
Dialysis [npop]
Session [evnt]
4 Weeks [tmco]
Half [qnco]
Group N [inpr]
Received [qlco]
Folic Acid [orch, phsu, vita]
therapy [ftcn]
Vitamin B 12 [orch, phsu, vita]
Intra [tmco]
therapy [ftcn]
homocysteine [aapp, bacs]
Decreased [qnco]
Received [qlco]
Folic Acid [orch, phsu, vita]
Vitamin B 12 [orch, phsu, vita]
Basal [spco]
Levels [qlco]
Control Groups [grup]
Decrease [qlco]
Received [qlco]
Folic Acid [orch, phsu, vita]
Mu [inpr]
mol/L [qnco]
P NOS [aapp, imft]
Conclusions [idcn]
homocysteine [aapp, bacs]
Children [aggp]
ESRD [dsyn]
Regular [qlco]
Haemodialysis [topp]
Combined therapy [topp]
Active [ftcn]
Form [qlco]
Folic Acid [orch, phsu, vita]
Vitamin B 12 [orch, phsu, vita]
Value [qnco]
Decreasing [qlco]
homocysteine [aapp, bacs]
Values [qlco]
Copyright [inpr]
basel [hcro]
